61 – 70 of 327
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A : Combined analysis of three studies
- Contribution to journal › Article
-
Mark
Moderate haemophilia in focus
- Contribution to journal › Debate/Note/Editorial
-
Mark
Coagulation factor VIII is vital for increasing global coagulation after physical exercise
- Contribution to journal › Article
-
Mark
Sports participation and physical activity in adult Dutch and Swedish patients with severe haemophilia : A comparison between intermediate- and high-dose prophylaxis
- Contribution to journal › Article
-
Mark
Cardiovascular disease-related hospitalization and mortality among persons with von Willebrand disease : A nationwide register study in Sweden
- Contribution to journal › Article
-
Mark
Joint comorbidities among Swedish carriers of haemophilia : A register-based cohort study over 22 years
- Contribution to journal › Article
- 2018
-
Mark
Replacement therapy during surgery in von Willebrand disease needs personalization
- Contribution to journal › Debate/Note/Editorial
-
Mark
The role of the laboratory in diagnosis and management of inhibitory antibodies in haemophilia
- Contribution to journal › Article
-
Mark
Fifth Åland Island conference on von Willebrand disease
- Contribution to journal › Article
-
Mark
Defining extended half-life rFVIII-A critical review of the evidence
- Contribution to journal › Article
